ATE514426T1 - Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure - Google Patents

Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure

Info

Publication number
ATE514426T1
ATE514426T1 AT01972783T AT01972783T ATE514426T1 AT E514426 T1 ATE514426 T1 AT E514426T1 AT 01972783 T AT01972783 T AT 01972783T AT 01972783 T AT01972783 T AT 01972783T AT E514426 T1 ATE514426 T1 AT E514426T1
Authority
AT
Austria
Prior art keywords
formulations
reducing
environmental hormone
ursodesoxycholic acid
eliminating environmental
Prior art date
Application number
AT01972783T
Other languages
English (en)
Inventor
Jae-Duck Yeon
Kyong-Up Baik
Kyu-Hyuck Jung
Seung-Kook Park
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Application granted granted Critical
Publication of ATE514426T1 publication Critical patent/ATE514426T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01972783T 2000-10-04 2001-09-28 Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure ATE514426T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0058127A KR100368936B1 (ko) 2000-10-04 2000-10-04 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
PCT/KR2001/001643 WO2002028396A1 (en) 2000-10-04 2001-09-28 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid

Publications (1)

Publication Number Publication Date
ATE514426T1 true ATE514426T1 (de) 2011-07-15

Family

ID=19691665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972783T ATE514426T1 (de) 2000-10-04 2001-09-28 Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure

Country Status (9)

Country Link
US (1) US20040029965A1 (de)
EP (1) EP1322315B1 (de)
JP (1) JP3883506B2 (de)
KR (1) KR100368936B1 (de)
CN (1) CN1204892C (de)
AT (1) ATE514426T1 (de)
AU (1) AU2001292423A1 (de)
ES (1) ES2368992T3 (de)
WO (1) WO2002028396A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
EP1809330B1 (de) * 2004-10-15 2011-04-27 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
KR19990009411A (ko) * 1997-07-09 1999-02-05 이웅열 간장질환치료에 우수한 의약조성물
BR9912395A (pt) * 1998-07-24 2001-10-16 Seo Hong Yoo Preparação de formas de dosagem de solução clara aquosa com ácidos biliares
KR100293764B1 (ko) * 1998-08-10 2001-09-17 박명규 인삼을주성분으로하는다이옥신독성해독제
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
KR100340763B1 (ko) * 1999-09-21 2002-06-20 김권 남성 생식기능 저하에 대한 예방 및 치료효과를 지닌 천연페놀 및 폴리페놀계 화합물을 포함하는 약제학적 조성물
KR20010037134A (ko) * 1999-10-14 2001-05-07 김원규 우루소데옥시콜린산을 함유하는 액제 및 그 제조방법
KR100401456B1 (ko) * 1999-12-24 2003-10-11 (주) 한국신과학 기술센타 수컷의 생식 독성 억제에 유효한 펙틴을 포함한 약학 조성물
KR20010087593A (ko) * 2000-03-08 2001-09-21 김권 남성 생식기능 저하 예방 및 치료 효과를 지닌클로로제닉산을 주요 성분으로 하는 약제학적 조성물
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제

Also Published As

Publication number Publication date
JP3883506B2 (ja) 2007-02-21
ES2368992T3 (es) 2011-11-24
CN1468103A (zh) 2004-01-14
KR20020026999A (ko) 2002-04-13
EP1322315B1 (de) 2011-06-29
EP1322315A1 (de) 2003-07-02
CN1204892C (zh) 2005-06-08
EP1322315A4 (de) 2004-05-26
US20040029965A1 (en) 2004-02-12
JP2004510739A (ja) 2004-04-08
WO2002028396A1 (en) 2002-04-11
KR100368936B1 (ko) 2003-01-24
AU2001292423A1 (en) 2002-04-15

Similar Documents

Publication Publication Date Title
IS6852A (is) Efnasambönd
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
EE200100487A (et) Uudsed ühendid ja kompositsioonid proteaasiinhibiitoritena
AP2003002742A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
DE60109938D1 (de) Zusammenstellungen die aktive stilbenoidverbindungen enthalten zur senkung des triglyceridspiegels
BR0012243A (pt) Triflúor butenos nematocidas
IT1288290B1 (it) Acido ialuronico autoreticolato e relative composizioni farmaceutiche per il trattamento delle artropatie
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
IL172773A (en) Formulations for the treatment of arthritis conditions
BR0308613A (pt) Combinação de compostos orgânicos
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
BR9811099A (pt) Inibidores de urocinase
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
ES2188979T3 (es) Derivados de benzamidina sustituidos con derivados de aminoacidos ciclicos e hidroxiacidos ciclicos, y su uso como anti-coagulantes.
ATE413179T1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE486852T1 (de) Salze von 9-oxoacridin-10-essigsäure mit 1- alkylamino-1-desoxypolyolen
SE9801494D0 (sv) Novel use
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
EE05318B1 (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hpogonadismi raviks
ATE514426T1 (de) Formulierungen zur verringerung oder eliminierung der toxizität von umwelthormonen mit ursodesoxycholsäure
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties